SMOX and chronic obstructive pulmonary disease: In a cell-free system, we found that phloretin demonstrated bacteriostatic and anti-biofilm activity against the COPD pathogens NTHi, M. catarrhalis, S. pneumoniae, and to a lesser extent, PAO1.